Opinion

New York State Teamsters Council Health and Hospital Fund v. Jazz Pharmaceuticals, Inc.

Court
District Court, N.D. California
Filed
Feb 28, 2025
Cited by
0 cases
Authority
More cited than 34.3%

explaining that the function of MDL procedure is “to promote 19 efficiency in a context involving the juggling of dozens or thousands of independent cases”

How later courts described this case

  • explaining that the function of MDL procedure is “to promote 19 efficiency in a context involving the juggling of dozens or thousands of independent cases”

Written by the judges who cited it.

The opinion

1

2

3

4

5

6

7 UNITED STATES DISTRICT COURT

8 NORTHERN DISTRICT OF CALIFORNIA

9

IN RE: XYREM (SODIUM OXYBATE)

10 ANTITRUST LITIGATION Case No. 20-md-02966-RS

11

ORDER DENYING MOTIONS FOR

12 This Document Relates To: All Actions SUGGESTION OF REMAND

13

14

15

Pursuant to Judicial Panel of Multidistrict Litigation (“JPML”) Rule 10.1(b)(i), 28 U.S.C.

16

§ 1407, and Local Civil Rule 7-1, Plaintiff United HealthCare Services, Inc. (“United”) and

17

Plaintiffs Blue Cross and Blue Shield of Florida, Inc., and Health Options, Inc. ( “Florida Blue”)

18

move for an order suggesting that the JPML remand their respective cases to the transferor courts

19

from whence they came. Because this court, acting as transferee, has resolved all summary

20

judgment and Daubert motions, United and Florida Blue (together, “Plaintiffs”) contend that the

21

pretrial proceedings for which their actions were transferred and coordinated have concluded.

22

Defendants Jazz Pharmaceuticals, Inc., Hikma Pharmaceuticals USA Inc., and their

23

affiliates (“Defendants”) oppose Plaintiffs’ remand motions, arguing that pretrial proceedings

24

remain ongoing. They specifically highlight anticipated “substantive motions in limine on issues

25

related to those briefed in the parties’ Daubert and summary judgment motions,” which they say

26

will go beyond questions about “whether specific evidence or testimony should be admitted at

27

trial.” Defs. Opp. Br., Dkt. No. 862 at 1–2.

1 Because pretrial proceedings remain ongoing, Plaintiffs’ motion is denied. By law, the

2 JPML must remand transferred actions to the transferor courts “no later than the conclusion of

3 pretrial proceedings in the transferee court.” Lexecon Inc. v. Milberg Weiss Bershad Hynes &

4 Lerach, 523 U.S. 26, 36–37 (1998); see also 28 U.S.C. § 1407(a) (conferring MDL jurisdiction

“for coordinated or consolidated pretrial proceedings”). Yet, courts have interpreted the phrase

5

“pretrial proceedings” broadly so as to encompass, inter alia, motions in limine. See 15 Charles

6

Alan Wright & Arthur R. Miller, Fed. Prac. & Proc. § 3866 (4th ed. 2024) (“Transferee courts

7

may decide . . . .motions in limine[.]); see also In re Parmalat Sec. Lit., No. 04-md-1653-LAK,

8

2007 WL 1169217, at *2 (S.D. N.Y. 2007) (transferee court ruling on motions in limine).

9

Plaintiffs cite In re: Cathode Ray Tube Antitrust Litigation, No. 07-cv-5944-JST, 2017 WL

10

8676440 (N.D. Cal. Apr. 5, 2017) for the proposition that pretrial proceedings conclude once

11

Daubert and summary judgment motions are dispatched. Although that court granted motions to

12

remand, it had previously ruled on various pretrial motions in limine. See, e.g., In re: Cathode

13

Ray Tube Antitrust Litigation, No. 07-cv-5944-JST, Dkt. No. 4982 (Oct. 26, 2016) (ruling on

14

motions in limine pertinent to 10 transferee actions, prior to granting remand motions). Thus,

15

contrary to Plaintiffs’ arguments, the notion of a transferee court retaining antitrust actions through

16

the resolution of common issues raised by motions in limine is hardly novel.

17

It is, however, more efficient—the entire point of MDLs. See In re Korean Air Lines Co.,

18

642 F.3d 685, 698 (9th Cir. 2011) (explaining that the function of MDL procedure is “to promote

19

efficiency in a context involving the juggling of dozens or thousands of independent cases”).

20

Even setting aside the motions in limine that Defendants anticipate, ongoing docket activity makes

21

clear that this MDL action continues to concern questions common to the individual actions it

22

comprises. See Dkt. No. 876 (Feb. 7, 2025) (motion to preclude Defendants from introducing

23

certain evidence). Resolving common issues is “among the reasons for the existence of

24

coordinated and consolidated pretrial proceedings,” which “enable[] a single judge, who often is

25

steeped in the intricacies of complex litigation, to bring that knowledge to bear and avoid[]

26

inconsistent results in trial courts.” In re Parmalat Sec. Litig., 2007 WL 1169217, at *2.

27

1 Plaintiffs also highlight a stipulated briefing schedule from May 2024 in which the parties

2 || agreed that their actions were subject to remand and “outside the scope of . . . the accompanying

3 schedule.” Dkt. No. 687 at 2. Because the schedule featured dates for motions in limine,

4 || Plaintiffs reason, Defendants’ agreement that Plaintiffs’ actions were “outside the scope”

5 || effectively conceded that any such motions in Plaintiffs’ actions would take place in the transferor

6 || courts. Defendants respond that, following the continuance of the trial date, the earlier stipulation

7 is now moot. They also note the extent to which Plaintiffs participated in some of the pretrial

8 exchanges, contrary to the stipulated schedule. At bottom, Defendants say, they agreed only that

9 || Plaintiffs may remand their case eventually—not that remand would follow whenever Plaintiffs

10 || wanted.

11 The stipulated briefing schedule does not require remand. Ultimately, when “pretrial

12 || proceedings have not been concluded, the question of whether remand is appropriate is left to the

5 13 court’s discretion and generally turns on the question of whether the case will benefit from further

14 || coordinated proceedings as part of the MDL.” Jn re Portfolio Recovery Assocs., LLC, Tel.

15 Consumer Prot. Act Litig., 2012 WL 1899798, at *1 (S.D. Cal. May 24, 2012). Whether

a 16 || Defendants properly preserved their right to oppose Plaintiffs’ motions is, frankly, irrelevant.

3 17 What matters is whether continued consolidation will benefit the case. Because it will, Plaintiffs’

18 || motions are denied.

19

20

21 IT IS SO ORDERED.

22

23 Dated: February 28, 2025

24

25 ICHARD SEEBORG _

Chief United States District Judge

26

27

98 ORDER DENYING MOTIONS FOR SUGGESTION OF REMAND

. CASE No. 20-md-02966-RS

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.